Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Enjoying worldwide respect
for the impact of their research, the basic scientists and clinical
investigators at Dana-Farber Cancer Institute are widely regarded as among the
world's most influential scientific minds. Our investigators are performing and
publishing work at the highest level – work that peers the world over have
recognized as vital to the advancement of their respective fields of cancer
As leaders in basic,
translational, clinical, and population science research, Dana-Farber researchers are advancing
the field of cancer research on every front. In precision cancer medicine, in
cancer immunotherapy, in genome discovery – we are taking a leadership role in
the complex fight against cancer. Our investigators are relentlessly probing
the molecular changes that cause tumors, testing new drug therapies, addressing
the needs of cancer survivors, and improving the delivery of care to diverse
To learn more about the many ways you can support Dana-Farber's research initiatives with a philanthropic gift, please contact Rebecca Shortle at 617-632-4215 or email@example.com.
Many Dana-Farber researchers maintain external
websites for their labs.
Read about the awards recently earned by Dana-Farber
Cancer Institute and our staff of researchers.
With a research career at Dana-Farber Cancer Institute, you'll play an important role in helping to fulfill our mission and ultimate goal: the eradication of cancer and related diseases.
Read about Dr. Kaelin's award, his scientific discoveries, his reactions to winning the award, and much more.
At Dana-Farber, we are committed to doing everything in our power to eliminate racial, socioeconomic, cultural, and other disparities in patient care, cancer research, and cancer treatment and outcomes.